Saule Technologies S.A. (WSE:SLT)

Market Cap	129.60M
Revenue (ttm)	5.68M
Net Income (ttm)	-65.49M
Shares Out	96.00M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,416
Average Volume	69,035
Open	1.300
Previous Close	1.350
Day's Range	1.300 - 1.395
52-Week Range	0.900 - 3.110
Beta	1.16
RSI	37.96
Earnings Date	Aug 12, 2025

About Revance Therapeutics

Saule Technologies S.A. engages in the research, development, manufacturing, and sale of perovskite solar cells. The company’s products portfolio includes energy-harvesting solar sun blinds, solar carports and others, electronic shelf labels, and photovoltaic glasses. Saule Technologies S.A. was founded in 2014 and is based in Warsaw, Poland.

• Industry: Investment Banking & Investment Services
• Sector: Financials
• Founded: 2014
• Employees: 60
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SLT

Financial Performance

In 2024, Saule Technologies's revenue was 1.31 million, a decrease of -7.24% compared to the previous year's 1.41 million. Losses were -65.79 million, 43.4% more than in 2023.